Director of UC San Diego Health's Level 4 Adult Epilepsy Center — the only nationally designated facility of its kind in the region — Dr. Jerry Shih is a board-certified neurologist and epileptologist who trained at UCLA and serves as Professor of Clinical Neurosciences at UCSD. His drug-resistant epilepsy program operates from the Hillcrest Medical Center at UC San Diego Health campus, where the multidisciplinary team performs intracranial EEG monitoring, laser ablation, responsive neurostimulation, and resective surgery. In 2023, Shih was part of the UCSD team that performed one of the first regenerative interneuron cell therapy procedures (NRTX-1001) in the United States for drug-resistant temporal lobe epilepsy. His clinic frequently coordinates referrals with general neurology offices in the corridor including Dr. James S. Grisolia, MD for shared management of patients whose seizures overlap with stroke, dementia, or movement-disorder presentations. The lab also publishes on intracranial speech recordings and bilingual brain-network organization in temporal lobe epilepsy. The most complex cases routed through this program are adults with non-lesional, multifocal pharmacoresistant epilepsy requiring stereo-EEG mapping before stem-cell or surgical intervention.